BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 23733335)

  • 1. Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment.
    Mussai F; De Santo C; Abu-Dayyeh I; Booth S; Quek L; McEwen-Smith RM; Qureshi A; Dazzi F; Vyas P; Cerundolo V
    Blood; 2013 Aug; 122(5):749-58. PubMed ID: 23733335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginase-mediated "field" defects in AML.
    Marcucci G
    Blood; 2013 Aug; 122(5):620-1. PubMed ID: 23908439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive role of CD11b
    Hyun SY; Na EJ; Jang JE; Chung H; Kim SJ; Kim JS; Kong JH; Shim KY; Lee JI; Min YH; Cheong JW
    Cancer Med; 2020 Oct; 9(19):7007-7017. PubMed ID: 32780544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Vγ9Vδ2 T cells specifically recognize and kill acute myeloid leukemic blasts.
    Gertner-Dardenne J; Castellano R; Mamessier E; Garbit S; Kochbati E; Etienne A; Charbonnier A; Collette Y; Vey N; Olive D
    J Immunol; 2012 May; 188(9):4701-8. PubMed ID: 22467661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of folate receptor β on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells.
    Lynn RC; Poussin M; Kalota A; Feng Y; Low PS; Dimitrov DS; Powell DJ
    Blood; 2015 May; 125(22):3466-76. PubMed ID: 25887778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice.
    Ailles LE; Gerhard B; Kawagoe H; Hogge DE
    Blood; 1999 Sep; 94(5):1761-72. PubMed ID: 10477702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration.
    Deng M; Gui X; Kim J; Xie L; Chen W; Li Z; He L; Chen Y; Chen H; Luo W; Lu Z; Xie J; Churchill H; Xu Y; Zhou Z; Wu G; Yu C; John S; Hirayasu K; Nguyen N; Liu X; Huang F; Li L; Deng H; Tang H; Sadek AH; Zhang L; Huang T; Zou Y; Chen B; Zhu H; Arase H; Xia N; Jiang Y; Collins R; You MJ; Homsi J; Unni N; Lewis C; Chen GQ; Fu YX; Liao XC; An Z; Zheng J; Zhang N; Zhang CC
    Nature; 2018 Oct; 562(7728):605-609. PubMed ID: 30333625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human acute myeloid leukemia blast-derived exosomes in patient-derived xenograft mice mediate immune suppression.
    Hong CS; Danet-Desnoyers G; Shan X; Sharma P; Whiteside TL; Boyiadzis M
    Exp Hematol; 2019 Aug; 76():60-66.e2. PubMed ID: 31369790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target.
    Mussai F; Egan S; Higginbotham-Jones J; Perry T; Beggs A; Odintsova E; Loke J; Pratt G; U KP; Lo A; Ng M; Kearns P; Cheng P; De Santo C
    Blood; 2015 Apr; 125(15):2386-96. PubMed ID: 25710880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Chemo-enzymatically Linked Bispecific Antibody Retargets T Cells to a Sialylated Epitope on CD43 in Acute Myeloid Leukemia.
    Bartels L; de Jong G; Gillissen MA; Yasuda E; Kattler V; Bru C; Fatmawati C; van Hal-van Veen SE; Cercel MG; Moiset G; Bakker AQ; van Helden PM; Villaudy J; Hazenberg MD; Spits H; Wagner K
    Cancer Res; 2019 Jul; 79(13):3372-3382. PubMed ID: 31064847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia.
    Zhang Q; Hossain DM; Duttagupta P; Moreira D; Zhao X; Won H; Buettner R; Nechaev S; Majka M; Zhang B; Cai Q; Swiderski P; Kuo YH; Forman S; Marcucci G; Kortylewski M
    Blood; 2016 Mar; 127(13):1687-700. PubMed ID: 26796361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Myeloid Leukemia Cells Express ICOS Ligand to Promote the Expansion of Regulatory T Cells.
    Han Y; Dong Y; Yang Q; Xu W; Jiang S; Yu Z; Yu K; Zhang S
    Front Immunol; 2018; 9():2227. PubMed ID: 30319662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.
    Distler E; Wölfel C; Köhler S; Nonn M; Kaus N; Schnürer E; Meyer RG; Wehler TC; Huber C; Wölfel T; Hartwig UF; Herr W
    Exp Hematol; 2008 Apr; 36(4):451-63. PubMed ID: 18261837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of IL-12Rβ2 in CD33(+)CD38(+) pediatric acute myeloid leukemia cells favours progression in NOD/SCID/IL2RγC-deficient mice.
    Ferretti E; Montagna D; Di Carlo E; Cocco C; Ribatti D; Ognio E; Sorrentino C; Lisini D; Bertaina A; Locatelli F; Pistoia V; Airoldi I
    Leukemia; 2012 Feb; 26(2):225-35. PubMed ID: 21844875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory T cells-derived IL-35 promotes the growth of adult acute myeloid leukemia blasts.
    Tao Q; Pan Y; Wang Y; Wang H; Xiong S; Li Q; Wang J; Tao L; Wang Z; Wu F; Zhang R; Zhai Z
    Int J Cancer; 2015 Nov; 137(10):2384-93. PubMed ID: 25866142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood acute myeloid leukemia in mice with severe combined immunodeficiency.
    Chelstrom LM; Gunther R; Simon J; Raimondi SC; Krance R; Crist WM; Uckun FM
    Blood; 1994 Jul; 84(1):20-6. PubMed ID: 8018918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity.
    Mussai F; Egan S; Hunter S; Webber H; Fisher J; Wheat R; McConville C; Sbirkov Y; Wheeler K; Bendle G; Petrie K; Anderson J; Chesler L; De Santo C
    Cancer Res; 2015 Aug; 75(15):3043-53. PubMed ID: 26054597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the arginine metabolic brake enhances immunotherapy for leukaemia.
    Mussai F; Wheat R; Sarrou E; Booth S; Stavrou V; Fultang L; Perry T; Kearns P; Cheng P; Keeshan K; Craddock C; De Santo C
    Int J Cancer; 2019 Oct; 145(8):2201-2208. PubMed ID: 30485425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the immunosuppressive microenvironment in acute myeloid leukemia development and treatment.
    Isidori A; Salvestrini V; Ciciarello M; Loscocco F; Visani G; Parisi S; Lecciso M; Ocadlikova D; Rossi L; Gabucci E; Clissa C; Curti A
    Expert Rev Hematol; 2014 Dec; 7(6):807-18. PubMed ID: 25227702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of gamma-irradiation on acute myelogenous leukemia blasts: in vitro studies of proliferation, constitutive cytokine secretion, and accessory cell function during T cell activation.
    Bruserud O; Ulvestad E
    J Hematother Stem Cell Res; 1999 Aug; 8(4):431-41. PubMed ID: 10634181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.